Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective study.

Date publication

octobre 2022

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles

Tous les auteurs :
Houvenaeghel G, de Nonneville A, Cohen M, Classe JM, Reyal F, Mazouni C, Faure C, Martinez A, Chauvet MP, Daraï E, Coutant C, Colombo PE, Gimbergues P, Azuar AS, Rouzier R, Tunon de Lara C, Crochet P, Rua S, Gonçalves A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36194904

Résumé

Few data have been reported regarding endocrine therapy (ET) in patients with small pT1a-b ER-postive breast cancer (BC). Thus, we conducted a study to detect possible survival improvements due to ET in such patients.

Mots clés

Aromatase inhibitors, Breast neoplasms, Disease-free survival, Multivariate analysis, Oestrogen receptors, Retrospective studies, Tamoxifen

Référence

Eur J Cancer. 2022 10 1;176:58-69